169 related articles for article (PubMed ID: 2976141)
1. Negative regulation of c-myc transcription involves myc family proteins.
Cleveland JL; Huleihel M; Bressler P; Siebenlist U; Akiyama L; Eisenman RN; Rapp UR
Oncogene Res; 1988; 3(4):357-75. PubMed ID: 2976141
[TBL] [Abstract][Full Text] [Related]
2. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
3. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
[TBL] [Abstract][Full Text] [Related]
4. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
5. Myc family of cellular oncogenes.
DePinho R; Mitsock L; Hatton K; Ferrier P; Zimmerman K; Legouy E; Tesfaye A; Collum R; Yancopoulos G; Nisen P
J Cell Biochem; 1987 Apr; 33(4):257-66. PubMed ID: 3034933
[TBL] [Abstract][Full Text] [Related]
6. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
7. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
8. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
Tavassoli M; Shall S
Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
[TBL] [Abstract][Full Text] [Related]
9. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
10. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
11. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
[TBL] [Abstract][Full Text] [Related]
13. c-myc and c-fos gene regulation during mouse liver regeneration.
Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
[TBL] [Abstract][Full Text] [Related]
14. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
Ray R; Thomas S; Miller DM
Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
[TBL] [Abstract][Full Text] [Related]
15. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
16. N-myc proto-oncogene expression can induce DNA replication in Balb/c 3T3 fibroblasts.
Cavalieri F; Goldfarb M
Oncogene; 1988 Mar; 2(3):289-91. PubMed ID: 3281096
[TBL] [Abstract][Full Text] [Related]
17. The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1.
van Dam H; Offringa R; Smits AM; Bos JL; Jones NC; van der Eb AJ
Oncogene; 1989 Oct; 4(10):1207-12. PubMed ID: 2529466
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cell cycle duration by c-myc levels.
Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
[TBL] [Abstract][Full Text] [Related]
19. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
20. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
Bandyopadhyay SK; D'Andrea E; Fleissner E
Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]